Labeler
Slate Run Pharmaceuticals, LLC NDC Codes
Slate Run Pharmaceuticals, LLC lists 109 finished drug products in the FDA NDC Directory under NDC labeler code 70436.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Diltiazem Hydrochloride, gadobutrol, iopamidol, olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide, Leucovorin Calcium, azithromycin dihydrate, Metoprolol succinate, Guanfacine, Memantine Hydrochloride, Vancomycin Hydrochloride, Eptifibatide, Cyclophosphamide, Cisatracurium besylate, sodium nitroprusside in 0.9% sodium chloride, droxidopa
- Active ingredients
- Diltiazem hydrochloride, Gadobutrol, Iopamidol, Olmesartan medoxomil, Amlodipine besylate, Hydrochlorothiazide, Leucovorin calcium, Azithromycin dihydrate, Sodium nitroprusside, Metoprolol succinate, Guanfacine hydrochloride, Memantine hydrochloride
- NDC labeler codes
- 70436
- Strengths (from the 100 most recently listed products)
- Gadobutrol 604.72 mg/mL; Olmesartan medoxomil 40 mg/1; Amlodipine besylate 5 mg/1; Hydrochlorothiazide 12.5 mg/1; Azithromycin dihydrate 200 mg/5mL; Hydrochlorothiazide 25 mg/1; Amlodipine besylate 10 mg/1; Iopamidol 408 mg/mL; Iopamidol 612 mg/mL; Cisatracurium besylate 2 mg/mL; Diltiazem hydrochloride 120 mg/1; Diltiazem hydrochloride 180 mg/1; Diltiazem hydrochloride 240 mg/1; Lincomycin 300 mg/mL; Sodium nitroprusside .2 mg/mL; Eptifibatide 2 mg/mL; Eptifibatide .75 mg/mL; Ganciclovir sodium 500 mg/10mL; Olmesartan medoxomil 20 mg/1; Cyclophosphamide 500 mg/25mL
- Dosage forms
- Injection, Tablet, Extended release, Injection, Powder, Lyophilized, For solution, Capsule, Extended release, Injection, Solution, Tablet, Film coated, Powder, For suspension, Injection, Powder, For solution, Capsule, Powder, For solution, Injection, Powder, Lyophilized, For suspension, Tablet, Delayed release, Tablet, Tablet, Film coated, Extended release, Injection, Solution, Concentrate
- Routes
- Oral, Intravenous, Intramuscular, Intravascular, Intrathecal
- Drug classes (FDA established)
- Calcium Channel Blocker, Gadolinium-based Contrast Agent, Radiographic Contrast Agent, Angiotensin 2 Receptor Blocker, Dihydropyridine Calcium Channel Blocker, Thiazide Diuretic, Folate Analog, Macrolide Antimicrobial, Vasodilator, beta-Adrenergic Blocker, Central alpha-2 Adrenergic Agonist, N-methyl-D-aspartate Receptor Antagonist, Glycopeptide Antibacterial, Platelet Aggregation Inhibitor, Nondepolarizing Neuromuscular Blocker, Cholinergic Muscarinic Antagonist, Serotonin and Norepinephrine Reuptake Inhibitor, Aminoketone, Tetracycline-class Drug, Antimetabolite Immunosuppressant, Vesicular Monoamine Transporter 2 Inhibitor, Osmotic Laxative, Potassium Salt, Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor, Nucleoside Analog Antiviral, Paramagnetic Contrast Agent, Muscle Relaxant, Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor, Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor, Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor, Azole Antifungal, Neuraminidase Inhibitor, Aminoglycoside Antibacterial, Lipopeptide Antibacterial, Proton Pump Inhibitor, Anticholinergic, Anti-coagulant, Direct Thrombin Inhibitor
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 160 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Bupropion Hydrochloride XLbupropion hydrochloride | Bupropion hydrochloride 150 mg/1 | Tablet, Extended releaseOral | 70436-010 | 70436-0010-0270436-0010-0470436-0010-06 | — |
| Bupropion Hydrochloride XLbupropion hydrochloride | Bupropion hydrochloride 300 mg/1 | Tablet, Extended releaseOral | 70436-011 | 70436-0011-0270436-0011-0470436-0011-06 | — |
| Potassium Chloride | Potassium chloride 600 mg/1 | Tablet, Film coated, Extended releaseOral | 70436-001 | 70436-0001-0170436-0001-0270436-0001-03 | — |
| Potassium Chloride | Potassium chloride 750 mg/1 | Tablet, Film coated, Extended releaseOral | 70436-002 | 70436-0002-0170436-0002-0270436-0002-03 | — |
| Cilostazol | Cilostazol 50 mg/1 | TabletOral | 70436-156 | 70436-0156-06 | — |
| Cilostazol | Cilostazol 100 mg/1 | TabletOral | 70436-157 | 70436-0157-06 | — |
| Galantamine | Galantamine hydrobromide 4 mg/1 | Tablet, Film coatedOral | 70436-004 | 70436-0004-06 | — |
| Galantamine | Galantamine hydrobromide 8 mg/1 | Tablet, Film coatedOral | 70436-005 | 70436-0005-06 | — |
| Galantamine | Galantamine hydrobromide 12 mg/1 | Tablet, Film coatedOral | 70436-006 | 70436-0006-06 | — |
Slate Run Pharmaceuticals, LLC: common questions
- What is Slate Run Pharmaceuticals, LLC's NDC labeler code?
- 70436. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Slate Run Pharmaceuticals, LLC?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.